Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors

In this session, you’ll gain: Clarity on high-impact early safety assays and their compelling rationale

Many early-stage biotechs show the same pattern: strong scientific progress paired with an operating discipline, the organization typically shifts from “busy but slightly lost” to “focused, aligned, and gaining

arrestin coupling — and whether the molecular glue framing offers a productive framework for targeting gain

In This Session, You’ll Gain Clarity on how ADME governs translational success A deeper understanding

Gaining control over disease-related events in non-alcoholic steatohepatitis (NASH), an advanced form

the interactions of SMO with cholesterol and other lipid molecules in the ciliary membrane, and to gain

While several gain-of-function mutations that lead to C-terminal truncations, frame shifts and point

receptors (SSTs) are class A GPCRs abundantly expressed in pituitary tumors where they represent the main

In This Session, You’ll Gain: ✅ The ability to calculate how many replicates you really  need for 95% By comparing two means (paired or unpaired) you’ll learn whether the divergence is genuine or whether

In this session, you’ll gain: ✅ Proven strategies  to balance in vitro vs. in vivo testing early — when

In this session, you’ll gain: ✅Clarity on Definitions:  What truly distinguishes orthosteric from allosteric

In this session, you’ll gain: ✅ A mental model you can trust  for predicting how GPCR ligands behave

In this session, you’ll gain: A framework for cancelling cell effects to isolate true receptor selectivity

In this lesson, you'll gain: ✅ Clarity on what “irreversible” really means  in kinetic and pharmacologic

In This Session, You’ll Gain: ✅ How to turn descriptive snapshots into predictive insights ✅ Tools to What looked like four conflicting behaviors turned out to be one coherent mechanism , hidden in plain

In this session, you’ll gain: Why saturation and displacement assays fail when protein stoichiometry

In this session, you’ll gain: How system sensitivity transforms potency, efficacy, and agonist classification

and partnerships are delayed, not by strategy, but by fear of cash burn 4️⃣ Fundraising becomes the main